| 1 |
35139776 | Metformin attenuates high glucose-induced injury in islet microvascular endothelial cells. | 2022 Feb |
3 |
| 2 |
34238029 | Metformin Antagonizes Ovarian Cancer Cells Malignancy Through MSLN Mediated IL-6/STAT3 Signaling. | 2021 Jan-Dec |
2 |
| 3 |
32452405 | Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia. | 2020 Jun |
1 |
| 4 |
33049108 | Metformin enhances osteogenic differentiation of stem cells from human exfoliated deciduous teeth through AMPK pathway. | 2020 Dec |
1 |
| 5 |
33081077 | Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. | 2020 Oct 16 |
1 |
| 6 |
30575815 | Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome. | 2019 Apr |
1 |
| 7 |
30710234 | Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study. | 2019 Apr |
1 |
| 8 |
31002375 | [Corrigendum] Metformin suppresses hypoxia‑induced migration via the HIF‑1α/VEGF pathway in gallbladder cancer in vitro and in vivo. | 2019 Jun |
1 |
| 9 |
31120617 | RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs. | 2019 Sep |
3 |
| 10 |
29670840 | Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line. | 2018 Mar |
1 |
| 11 |
29678660 | Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. | 2018 Jul 20 |
3 |
| 12 |
30272364 | Metformin suppresses hypoxia‑induced migration via the HIF‑1α/VEGF pathway in gallbladder cancer in vitro and in vivo. | 2018 Dec |
4 |
| 13 |
30372835 | Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells. | 2018 Dec |
1 |
| 14 |
28427181 | Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK. | 2017 May 16 |
1 |
| 15 |
29344202 | Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2. | 2017 Dec |
1 |
| 16 |
26305116 | Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR-signaling pathway. | 2016 Jul |
1 |
| 17 |
26861446 | Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. | 2016 Feb 9 |
3 |
| 18 |
27378194 | Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning. | 2016 Sep |
1 |
| 19 |
25179820 | The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells. | 2015 Jan 5 |
1 |
| 20 |
25785990 | Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1. | 2015 |
1 |
| 21 |
25981877 | Metformin as possible therapy of pulmonary arterio venous malformation in HHT patients. | 2015 Sep |
1 |
| 22 |
26260219 | Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. | 2015 Oct |
2 |
| 23 |
26625311 | Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. | 2015 Dec 29 |
4 |
| 24 |
24419232 | Paradoxic effects of metformin on endothelial cells and angiogenesis. | 2014 May |
3 |
| 25 |
23225247 | Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase. | 2013 May |
6 |
| 26 |
23526220 | Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. | 2013 Aug |
1 |
| 27 |
23879009 | [Metformin--new treatment strategies for gynecologic neoplasms]. | 2013 |
1 |
| 28 |
24011132 | Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study. | 2013 Sep 8 |
1 |
| 29 |
22469973 | Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway. | 2012 Jun |
2 |
| 30 |
22576211 | Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. | 2012 Apr |
2 |
| 31 |
23653852 | Anti-angiogenic Effects of Metformin, an AMPK Activator, on Human Umbilical Vein Endothelial Cells and on Granulation Tissue in Rat. | 2012 Nov |
1 |
| 32 |
21532889 | Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | 2011 May |
1 |
| 33 |
18256928 | Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. | 2009 Jan |
3 |
| 34 |
18358555 | The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. | 2008 Jul |
4 |